Retraction
Glioma-Derived ADAM10 Induces Regulatory B Cells to Suppress CD8+ T Cells
Paper Information
Record ID:
26820
Publication Date:
August 15, 2014
Retraction Date:
March 19, 2021
(4.7 years years ago)
Subjects:
Institution:
Department of neurosurgery, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0249104Additional Notes:
see also: https://pubpeer.com/publications/4011EC4373F98312E86BBDD7126FF8;
Citations (20)
20
Total Citations9
Post-Retraction(45.0%)
10
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
5
After 2+ years
1372
Days since retraction (latest)
A novel risk model consisting of nine platelet-related gene signatures for predicting prognosis, immune features and drug sensitivity in glioma
Shuang Wei, Ju Zhou, Bin Dong
Hereditas
Open Access
Published: Dec 2024
1 citation
1 citation
1372 days after retraction
<scp>ADAM10</scp> modulates the efficacy of T‐cell‐mediated therapy in solid tumors
Ahmed M. E. Abdalla, Miao Yu, Ning Ming et al. (4 authors)
Immunology and Cell Biology
Published: Oct 2024
1 citation
1 citation
1308 days after retraction
A Novel Discovery of CXCL5 in Prognosis Prediction and Targeted Therapy of Glioblastomas
Hui Li, Lu Han, Jianxin Xi et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Aug 2024
1248 days after retraction
Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment
Tongzheng Chen, Wenbin Ma, Xin Wang et al. (10 authors)
Journal of Advanced Research
Open Access
Published: Aug 2024
2 citations
2 citations
1231 days after retraction
Current approaches in glioblastoma multiforme immunotherapy
Marjan Aghajani, Nazila Jalilzadeh, Ali Aghebati‐Maleki et al. (9 authors)
Clinical & Translational Oncology
Published: Mar 2024
14 citations
14 citations
1098 days after retraction
Immunomodulatory role of metalloproteases in cancers: Current progress and future trends
Qi Wang, Kai Wang, Xiaojing Tan et al. (5 authors)
Frontiers in Immunology
Open Access
Published: Dec 2022
25 citations
25 citations
637 days after retraction
High Expression of CISD2 in Relation to Adverse Outcome and Abnormal Immune Cell Infiltration in Glioma
Fang Zhang, Hua-Bao Cai, Han-Ze Liu et al. (10 authors)
Disease Markers
Open Access
Published: Apr 2022
9 citations
9 citations
398 days after retraction
Immunological Tolerance
Pooya Farhangnia, Mahzad Akbarpour
Elsevier eBooks
Published: Oct 2021
7 citations
7 citations
214 days after retraction
Natural Antibodies: Protecting Role of IgM in Glioblastoma and Brain Tumours
Shubham Semwal, Rabah Boukherroub, Savvas N. Savvides et al. (4 authors)
Current Pharmaceutical Design
Open Access
Published: Jul 2021
132 days after retraction
Retraction: Glioma-Derived ADAM10 Induces Regulatory B Cells to Suppress CD8+ T Cells
Zhuopeng Ye, Haiyong He, Hui Wang et al. (7 authors)
PLoS ONE
Open Access
Published: Mar 2021
Same day as retraction
Myeloid Cells in Glioblastoma Microenvironment
Alessandra De Leo, Alessio Ugolini, Filippo Veglia
Cells
Open Access
Published: Dec 2020
116 citations
116 citations
85 days before retraction
Explicating the Pivotal Pathogenic, Diagnostic, and Therapeutic Biomarker Potentials of Myeloid-Derived Suppressor Cells in Glioblastoma
Seidu A. Richard
Disease Markers
Open Access
Published: Nov 2020
14 citations
14 citations
135 days before retraction
The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
Yajing Mi, Na Guo, Jing Luan et al. (8 authors)
Frontiers in Immunology
Open Access
Published: Apr 2020
116 citations
116 citations
329 days before retraction
Regulatory B Cells
Luman Wang, Ying Fu, Yiwei Chu
Advances in experimental medicine and biology
Published: Jan 2020
61 citations
61 citations
443 days before retraction
Myeloid-Derived Suppressive Cells Promote B cell–Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma
Catalina Lee-Chang, Aida Rashidi, Jason Miska et al. (16 authors)
Cancer Immunology Research
Open Access
Published: Sep 2019
141 citations
141 citations
549 days before retraction
Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma
Qianquan Ma, Wenyong Long, Changsheng Xing et al. (8 authors)
Frontiers in Immunology
Open Access
Published: Dec 2018
204 citations
204 citations
819 days before retraction
ADAM protein family – its role in tumorigenesis, mechanisms of chemoresistance and potential as diagnostic and prognostic factors
Łukasz Zadka, Michał Kulus, Katarzyna Piątek
Neoplasma
Open Access
Published: Jan 2018
13 citations
13 citations
1173 days before retraction
Positive and negative functions of B lymphocytes in tumors
Meng Shen, Qian Sun, Jian Wang et al. (5 authors)
Oncotarget
Open Access
Published: Jun 2016
51 citations
51 citations
1738 days before retraction
The Role of the Immune System in the Effects of Cancer on Bone
Rebecca Silbermann, G. David Roodman
Elsevier eBooks
Published: Sep 2015
2002 days before retraction
Activation of Glioma Cells Generates Immune Tolerant NKT Cells
Bo Tang, Wei Wu, Xiaowei Wei et al. (6 authors)
Journal of Biological Chemistry
Open Access
Published: Oct 2014
27 citations
27 citations
2338 days before retraction
Quick Stats
Total Citations:
20
Years Since Retraction:
4.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025